RPRX
Royalty Pharma plcNASDAQStock$65.11+0.37 (+0.57%)Mkt Cap 29.0BP/E 36.51Div Yield 1.49%Beta 0.41Vol 1.2MAvg Vol 3.3M
52W$36.41
$65.11
ETFs That Hold RPRX (Royalty Pharma plc)
1M
+11.55%
3M
+10.02%
6M
+29.99%
YTD
+67.55%
1Y
+74.75%
3Y
+143.86%
5Y
+70.45%
ETFs That Hold RPRX
Royalty Pharma plc is held by 205 ETFs. The largest position by market value is in VFLO (VictoryShares Free Cash Flow ETF).
| ETF | Fund Name | Weight |
|---|---|---|
| TOK | iShares MSCI Kokusai ETF | 0.03% |
| AVTM | Avantis Total Equity Markets ETF 1 | 0.01% |
| DURA | VanEck Durable High Dividend ETF | 0.17% |
| ONOF | Global X - Adaptive U.S. Risk Management ETF | 0.04% |
| PTNT | Corgi ETF Trust I - Corgi IP Licensing & Royalties ETF | 4.68% |
| STXV | Strive 1000 Value ETF | 0.07% |
| QARP | Xtrackers Russell 1000 US Quality at a Reasonable Price ETF | 0.06% |
| FFF | Founders 100 ETF | 0.69% |
| QQJG | Invesco ESG NASDAQ Next Gen 100 ETF | 0.63% |
| STXG | Strive 1000 Growth ETF | 0.03% |
| RKSG | Ruk Strategic Growth ETF | 0.90% |
| VLLU | Harbor AlphaEdge Large Cap Value ETF (VLLU) | 0.53% |
| AVIE | Avantis Inflation Focused Equity ETF | 0.15% |
| HAWG | HCM Hedged Equity ETF | 0.02% |
| DVVY | Invesco Actively Managed Exchange-Traded Fund Trust - Invesco Diversified Dividend Opportunities ETF | 0.74% |
| TACU | T. Rowe Price Active Core U.S. Equity ETF | 0.12% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.02% |
| LVHB | Innovator Laddered Allocation Power Buffer ETF | 0.00% |
| STMB | iShares Trust - iShares Factors US Mid Blend Style ETF | 0.34% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.02% |
Excludes leveraged and inverse ETFs.
Frequently Asked Questions
How many ETFs hold RPRX?
Royalty Pharma plc (RPRX) is held by 205 ETFs (excluding leveraged and inverse funds). The largest position by market value is in VFLO (VictoryShares Free Cash Flow ETF).
What is the largest ETF that holds RPRX?
By fund size, VFLO (VictoryShares Free Cash Flow ETF) with $12.33B in AUM holds 1.72% of its portfolio in RPRX, representing $213.1M in market value.
What percentage of PBE is RPRX?
RPRX makes up 5.10% of PBE (Invesco Biotechnology & Genome ETF), making it one of the largest positions in that fund.
Is RPRX in the S&P 500?
RPRX is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.